Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ensifentrine
ensifentrine
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024
BioSpace
Wed, 03/27/24 - 11:06 am
COPD
Sanofi
Regeneron
Verona Pharma
Dupixent
ensifentrine
After decades of waiting, late-stage therapies may penetrate the COPD market this year
Clinical Trials Arena
Sun, 03/24/24 - 10:31 pm
COPD
drug development
Sanofi
Regeneron
Dupixent
Verona
ensifentrine
Verona Pharma Eyes NDA for COPD Drug Based on Positive Phase III Data
BioSpace
Wed, 12/21/22 - 12:00 am
Verona Pharma
COPD
ensifentrine
Boost for Verona Pharma after trial win with inhaled COPD drug
Pharmaforum
Tue, 02/2/21 - 10:37 am
Verona Pharma
COPD
ensifentrine
clinical trials
Verona to test COPD hopeful ensifentrine in COVID-19 patients
Pharmaforum
Tue, 09/8/20 - 10:30 pm
Verona Pharma
COVID-19
COPD
ensifentrine
Verona Pharma to trial lung drug ensifentrine for COVID-19
Pharmaforum
Fri, 08/14/20 - 09:46 am
Verona Pharma
ensifentrine
COVID-19
After nebulizer flop, Verona touts interim PhII results on another version of its lead COPD drug
Endpoints
Mon, 03/4/19 - 10:22 am
Verona
clinical trials
ensifentrine
COPD